Medical News

RSS

Combination of antibiotics can cure Chlamydia-induced ReA: Study

Researchers from University of South Florida College of Medicine found a combination of antibiotics to be an effective treatment for Chlamydia-induced reactive arthritis, a major step forward in the management, and possibly cure, of this disease. Results of this study are published in the May issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.

29 Apr 2010

A new approach for treating neurological and degenerative disorders

In studies on cancer, heart disease, neurological disorders and other degenerative conditions, some scientists are moving away from the "nature versus nurture" debate, and are finding you're not a creature of either genetics or environment, but both - with enormous implications for a new approach to health.

29 Apr 2010

Odyssey HealthCare reports 53.7% increase in first-quarter net income attributable to stockholders

Odyssey HealthCare, Inc., one of the largest providers of hospice care in the United States, today announced financial results for the first quarter ended March 31, 2010.

29 Apr 2010

Great American Asthma Challenge movement to change asthma care in the U.S.

Every day 10 people die from asthma. Most healthcare providers agree that these deaths are preventable. Patient education, access to care and a healthy lifestyle are proven methods that lead to less severe asthma symptoms, fewer hospitalizations and emergency department visits, fewer missed days of school and work - and fewer deaths.

29 Apr 2010

Three new biomarkers for ductal carcinoma in situ found

A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.

29 Apr 2010

Healthy food programs in grocery stores may help reduce diet-related illnesses

Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.

29 Apr 2010

Celladon's first Phase II trial of MYDICAR for advanced heart failure meets primary endpoint

Targeted Genetics Corporation announced today that its licensing partner, Celladon Corporation, has reported today that Celladon's first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.

29 Apr 2010

ONDCP launches new anti-meth ad campaign for Indian Country

White House Office of National Drug Control Policy Director Gil Kerlikowske today unveiled a new anti-methamphetamine ad campaign tailored for Indian Country, launched in New Mexico and in 14 other states with the largest Native American populations.

29 Apr 2010

China lifts decades-old HIV/AIDS travel ban

Late Tuesday, China's State Council lifted a decades-old restriction that banned foreigners with HIV/AIDS from entering the country, Reuters reports (Buckley, 4/27). The amended rules, which appear on the government website, also lift a travel ban on foreigners with other sexually transmitted diseases and leprosy, and "narrow the travel restriction on people with tuberculosis, to those with an infectious form of the lung disease," according to Bloomberg Businessweek (Randall, 4/28).

29 Apr 2010

Young adults seeking coverage on parents' plans face obstacles

Young adults and their parents eager to take advantage of a new law that will allow parents of children up to age 26 to keep their children on their health plans are facing obstacles in learning even exactly when they'll be eligible.

29 Apr 2010

Renowned cardiologists to discuss latest research on Hypertrophic Cardiomyopathy at HCMA symposium

Hypertrophic Cardiomyopathy (HCM), the genetic disease in which the muscle of the heart thickens in the absence of an apparent cause, is the leading cause of sudden death in children and young adults. HCM accounts for 40 percent of all deaths on athletic playing fields across the U.S.

29 Apr 2010

DFine granted US patent relating to StabiliT Vertebral Augmentation System

DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures, announced today that the United States Patent & Trademark Office has issued Patent 7,678,116 relating to the StabiliT® Vertebral Augmentation System. Two additional Notices of Allowance have also been issued with patents expected later this year.

29 Apr 2010

New study reinforces urgent need for life-saving vaccines in Africa

A new study released this week in The Lancet Infectious Diseases finds that African children who contract pneumococcus - a bacterial infection that causes pneumonia, meningitis and sepsis - are 36 times as likely to have sickle-cell disease, a blood disorder prevalent in African children that increases the risk for infectious diseases and early death.

29 Apr 2010

Salvation Army gets a boost from Westpac

The Salvation Army’s fundraising efforts received a major shot in the arm from Westpac boss Gail Kelly. The banker told the business leaders that the bank would match the New South Wales state government’s contribution of $200,000 to the 2010 Red Shield Appeal.

29 Apr 2010

New research indicates Canadians live longer than Americans

Compared to their neighbours south of the border, Canadians live longer, healthier lives. Research published in BioMed Central's open access journal Population Health Metrics has found this disparity between the two countries, suggesting that America's lack of universal health care and lower levels of social and economic equality are to blame.

29 Apr 2010

Lycera to advance discovery, development efforts with second tranche of $11 million Series A financing

Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, today announced that the company has made important progress, triggering a second tranche of $11 million in its Series A financing. Proceeds from the second tranche will be used to continue to advance Lycera's discovery and development efforts and further support the growth of the company.

29 Apr 2010

NIH approves federal funding for 13 more stem cell lines

The Washington Post: Thirteen more lines of human embryonic stem cells are officially eligible for federal funding, since being approved by the National Institutes of Health. The Obama administration announced shortly after the President took office that restrictions would be lifted on the use of federal funds for embryonic stem cell research.

29 Apr 2010

Stericycle's first-quarter 2010 revenues up 21.0%

Stericycle, Inc., today reported financial results for the first quarter of 2010.

29 Apr 2010

Ceregene continues enrollment in new Phase 1/2 clinical study of CERE-120 for Parkinson's disease

Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.

29 Apr 2010

Uninsured patients less likely to receive critical care services

Among the general U.S. population, people who are uninsured are about half as likely to receive critical care services as those with insurance, according to systematic review of the literature by the American Thoracic Society's Health Disparities Group.

29 Apr 2010